Auger William R, Fedullo Peter F
Division of Pulmonary and Critical Care Medicine, University of California, San Diego, LaJolla, California 92037, USA.
Semin Respir Crit Care Med. 2009 Aug;30(4):471-83. doi: 10.1055/s-0029-1233316. Epub 2009 Jul 24.
The last 4 decades have witnessed dramatic changes in the treatment of patients with pulmonary hypertension. And with the advances in cardiothoracic surgical techniques, selected patients with chronic thromboembolic pulmonary hypertension (CTEPH) are afforded a surgical remedy for their disease. In the vast majority of these patients, surgical endarterectomy of chronic thromboemboli from the pulmonary vascular bed effectively treats even severe pulmonary hypertension, and as a result, the debilitating symptoms of right heart dysfunction. This article reviews the natural history of chronic thromboembolic disease and outline a suggested diagnostic approach to determine whether a patient with chronic thromboembolic disease might be an appropriate surgical candidate. Pulmonary thromboendarterectomy surgery, and the growing information on the use of pharmacotherapy in inoperable CTEPH, are also reviewed.
在过去的40年里,肺动脉高压患者的治疗发生了巨大变化。随着心胸外科技术的进步,部分慢性血栓栓塞性肺动脉高压(CTEPH)患者获得了针对其疾病的手术治疗方法。在绝大多数这类患者中,通过手术从肺血管床切除慢性血栓栓子,即使是严重的肺动脉高压也能得到有效治疗,进而缓解右心功能不全带来的虚弱症状。本文回顾了慢性血栓栓塞性疾病的自然病史,并概述了一种建议的诊断方法,以确定慢性血栓栓塞性疾病患者是否可能是合适的手术候选者。还将对肺动脉血栓内膜剥脱术以及关于无法手术的CTEPH患者药物治疗应用的越来越多的信息进行综述。